GLUE-DAC Trademark
Trademark Overview
On Wednesday, November 12, 2025, a trademark application was filed for GLUE-DAC with the United States Patent and Trademark Office. The USPTO has given the GLUE-DAC trademark a serial number of 99493141. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 23, 2026. This trademark is owned by Fortitude Biomedicines, Inc.. The GLUE-DAC trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the development of autoimmune disease and cancer therapeutics
Development of pharmaceutical preparations for the treatment of autoimmune disease and cancer; development of platform technology, namely, immunotherapy platforms for manufacturing autoimmune disease and cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
General Information
| Serial Number | 99493141 |
| Word Mark | GLUE-DAC |
| Filing Date | Wednesday, November 12, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, March 23, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the development of autoimmune disease and cancer therapeutics |
| Pseudo Mark | GLUE DAC |
| Goods and Services | Development of pharmaceutical preparations for the treatment of autoimmune disease and cancer; development of platform technology, namely, immunotherapy platforms for manufacturing autoimmune disease and cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes |
| Pseudo Mark | GLUE DEGRADER ANTIBODY CONJUGATE |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 12, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 12, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Fortitude Biomedicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, November 12, 2025 | NEW APPLICATION ENTERED |
| Wednesday, November 12, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, March 17, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 23, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 23, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 23, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 23, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 22, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, May 22, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
